BOUL Boule Diagnostics AB (publ)

2.340SEK-2.90%Mkt Cap: 8.69M $P/E: —

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and …

Key Statistics

Company
Market Cap8.69M USD
Enterprise Value28.82M USD
Revenue (TTM)44.12M USD
Gross Profit20.45M USD
Net Income (TTM)-358.98K USD
Revenue/Share13.01 SEK
Last Price2.340 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees200
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)2.13
PEG—
EV/EBITDA13.91
EV/Revenue0.65
P/S0.20
P/B0.54
EPS (TTM)-0.10
EPS (Forward)1.13
52W Range
2.2103% of range6.640
52W High6.640 SEK
52W Low2.210 SEK
Profitability
Gross Margin43.66%
Oper. Margin2.94%
EBITDA Margin4.69%
Profit Margin-0.77%
ROE-2.24%
ROA-0.80%
Growth
Revenue Growth-13.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF79.30K USD
CapEx (TTM)474.72K USD
FCF Margin0.21%
FCF Yield1.09%
Net Debt19.87M USD
Net Debt/EBITDA9.59
Balance Sheet
Debt/Equity1.33
Current Ratio1.07
Quick Ratio0.68
Book Value/Sh4.50 SEK
Cash/Share0.51 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield0.52%
Payout Ratio0.00%
Ex-Div DateMay 6, 2022
Pay Date—
Splits
Last Split4:1
Split DateJun 1, 2018
Analyst Consensus
Rating—
Target (Mean)3.800 SEK
Upside (mean)+62.4%
Target Range3.800 SEK – 3.800 SEK
# Analysts1
Ownership
Shares Out.38.83M
Float22.80M
Insiders35.31%
Institutions49.20%
Technical
SMA 503.070 (-23.8%)
SMA 2003.807 (-38.5%)
Beta0.17
S&P 52W Chg14.58%
Avg Vol (30d)46.42K
Avg Vol (10d)31.35K
Technical Indicators
RSI (14)36.8
MACD-0.2158
MACD Signal-0.2310
MACD Hist.+0.0152
BB Upper2.972 SEK
BB Middle2.517 SEK
BB Lower2.061 SEK
BB Width36.22%
ATR (14)0.1766 SEK
Vol Ratio (20d)0.22x